文献速递颈动脉与弓上血管

经颈动脉血运重建术后卒中风险升高的患者识别

Identifying patients at elevated risk of stroke after transcarotid artery revascularization.
PubMed 文献 · J Vasc Surg · 2026-06-20

基于血管质量倡议(VQI)2016至2024年61,111例经颈动脉血运重建(TCAR)患者数据,采用CART与随机森林两种机器学习方法识别院内卒中相关因素。总体院内卒中风险为1.33%,症状状态、未依从P2Y12抑制剂及使用两枚及以上支架是最重要因素,四组风险自0.74%递增至3.96%。

要点

  • TCAR总体院内卒中风险为1.33%,症状状态、P2Y12抑制剂依从性与支架数量是关键分层因素。
  • 无症状且P2Y12依从者风险0.74%,症状且置入两枚及以上支架者风险达3.96%。
  • 无法可靠依从术前药物治疗的无症状患者或无法单支架治疗的症状患者可考虑其他血运重建策略。

核心结论

  • 症状状态、未依从P2Y12抑制剂及使用两枚及以上支架与TCAR后院内卒中风险升高相关。
  • 上述因素中P2Y12抑制不可靠与多支架操作是院内卒中的强预测因素。

研究设计与样本

  • 回顾性分析血管质量倡议(VQI)数据,纳入2016至2024年接受TCAR的患者61,111例,平均年龄73.4±8.9岁,女性37.4%,症状性42.1%。
  • 采用分类与回归树(CART)识别相关因素并分组,采用随机森林识别最重要特征,再用逻辑回归校正随机森林筛出的主要变量混杂。

主要发现

  • TCAR后总体院内卒中风险为1.33%。
  • CART分组院内卒中风险:G1无症状且P2Y12依从0.74%,G2无症状且未服术前P2Y12抑制剂1.60%,G3症状性且单支架1.85%,G4症状性且两枚及以上支架3.96%。
  • 校正混杂后院内卒中风险逐步升高:以G1为参照,G2的aOR为1.77(95%CI:1.27-2.47),G3的aOR为2.36(95%CI:2.00-2.77),G4的aOR为5.29(95%CI:4.07-6.87)。

关键数值与推荐

  • 院内卒中风险分层:G1为0.74%、G2为1.60%、G3为1.85%、G4为3.96%。
  • 校正后风险比较:G2的aOR 1.77(95%CI:1.27-2.47)、G3的aOR 2.36(95%CI:2.00-2.77)、G4的aOR 5.29(95%CI:4.07-6.87),均以G1为参照。

临床怎么用

  • 术前评估应关注患者对P2Y12抑制剂的依从性,依从不佳者需谨慎选择TCAR。
  • 对无症状但无法可靠依从术前药物治疗者,可考虑替代血运重建策略。
  • 对症状性且预计需置入两枚及以上支架者,应权衡TCAR与其他血运重建方式。

局限性

  • 原文摘要未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transcarotid artery revascularization (TCAR) has assumed a significant role in the surgical treatment of extracranial carotid occlusive disease in current practice. Yet, TCAR-specific factors that predispose to periprocedural stroke remain poorly characterized. The purpose of this analysis was to identify factors that may inherently predispose to adverse outcomes in patients undergoing TCAR. METHODS: We used Vascular Quality Initiative data to examine factors associated with in-hospital stroke after TCAR for patients treated between 2016 and 2024. Two complementary machine learning methods were used to identify factors associated with stroke after TCAR. First, we used classification and regression trees (CART) to identify factors associated with stroke and then grouped patients according to these factors. Second, we used a random forest machine learning technique to identify the top features associated with stroke. Finally, we took the CART-defined subgroups and used logistic regression to account for confounding by the top variables from the random forest. RESULTS: We studied 61,111 patients who underwent TCAR (mean age: 73.4 ± 8.9 years, 37.4% women, 42.1% symptomatic). The overall in-hospital stroke risk was 1.33% after TCAR. The CART analysis found that most important factors associated with in-hospital stroke were symptom status, noncompliance with taking a p2y12 inhibitor, and the use of two or more stents. This created four patient groups: (G1) asymptomatic and p2y12 inhibitor compliant, (G2) asymptomatic and not taking a preoperative P2Y12 inhibitor, (G3) symptomatic and with one stent, and (G4) symptomatic and with two or more stents. These groups had in-hospital stroke risks of 0.74%, 1.60%, 1.85%, and 3.96%, respectively. After adjustment for confounding, the groups had a stepwise increase in the likelihood of in-hospital stroke: G1: reference, G2: adjusted odds ratio (aOR): 1.77 (95% confidence interval [CI]: 1.27-2.47), G3: aOR: 2.36 (95% CI: 2.00-2.77), and G4: aOR: 5.29 (95% CI: 4.07-6.87). CONCLUSIONS: There appear to be important modifiable factors that are associated with increased in-hospital stroke risk among patients undergoing TCAR. Specifically, unreliable p2y12 inhibition and multistent procedures were strong predictors of in hospital stroke. These findings suggest that asymptomatic patients who cannot satisfactorily comply with preoperative medical therapy or symptomatic patients who cannot be treated with a single stent may wish to consider an alternative revascularization strategy.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Columbo JA, Martinez-Camblor P, Hicks CW, et al. Identifying patients at elevated risk of stroke after transcarotid artery revascularization. J Vasc Surg. 2026. PMID: 42323112. doi:10.1016/j.jvs.2026.06.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。